Opiophobia in Adults With Advanced Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-08-01

Study Completion Date

2031-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To explore the barriers and fears related to use of opioids among a population of adult outpatients with advanced cancer who continue to experience pain after receiving a prescription for opioid analgesia and hypothesized associations among opiophobia, anxiety, depression, pain intensity, pain interference, and opioid medication adherence.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain

NCT00513656

Cancer Pain Constipation

COMPLETED PHASE2

Self Reported Deviations From Opioid Analgesic Prescription

NCT00907192

Advanced Cancers

COMPLETED

Opioid Misuse in Patients with Cancer

NCT06489769

Cancer Opioid Use Opioid Misuse +2 more

RECRUITING

Individualized Pharmaceutical-care in Outpatients With Cancer Pain

NCT03439904

Cancer Pain

UNKNOWN NA

Precision Medicine Guided Treatment for Cancer Pain

NCT02664350

Pain CYP2D6 Polymorphism

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary Objective:

To explore the barriers and fears related to use of opioids among a population of adult outpatients with advanced cancer who continue to experience pain after receiving a prescription for opioid analgesia.

Secondary Objective:

To examine associations among opiophobia, anxiety, depression, pain intensity, pain interference, and opioid medication adherence among adults with advanced cancer who report undermanaged pain during the first week after receiving a prescription for an opioid analgesic.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adult patients with advanced cancer (defined as cancer that is unlikely to be cured and is locally advanced or distantly metastasized
2. Pain is the documented reason for the Supportive Care consultation
3. Have a prescription for an opioid analgesic
4. Able to read, speak, and consent in English.

Exclusion Criteria

1. Age less than 18 years
2. Do not have a prescription for an opioid analgesic
3. Individuals for whom there is documentation of inability to provide consent in the medical record
4. Women who are pregnant
5. Patients with a substance use disorder (including alcohol use disorder and excluding tobacco use disorder) documented in the electronic health record under History of Present Illness or in the Medical History.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No